Sg Americas Securities, LLC Cue Biopharma, Inc. Transaction History

Sg Americas Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$10.86 - $17.85 $118,504 - $194,779	-10,912 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$10.06 - $15.3 $109,774 - $166,953	10,912 New	10,912 $159,000
Q4 2020 Feb 04, 2021	SELL	$11.12 - $16.4 $182,790 - $269,583	-16,438 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$15.05 - $23.54 $147,700 - $231,021	9,814 Added 148.16%	16,438 $247,000
Q2 2020 Jul 20, 2020	SELL	$12.7 - $30.73 $9,512 - $23,016	-749 Reduced 10.16%	6,624 $162,000
Q1 2020 Apr 30, 2020	BUY	$9.85 - $22.27 $72,624 - $164,196	7,373 New	7,373 $105,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.